Prevalence and Risk Factors for Minor Hallucinations in Patients with Parkinson’s Disease

Table 4

Logistic regression analyses for independent predictors of minor hallucinations.

	OR	95% CI
Disease duration	0.984	0.913-1.061	0.672
Levodopa	0.569	0.234-1.382	0.213
Dopamine agonists	0.801	0.386-1.664	0.552
PDSS	0.988	0.976-0.999	0.032
MoCA	1.043	0.978-1.112	0.201
HAMD	0.952	0.885-1.024	0.189
RBDSQ	1.136	1.018-1.268	0.023
PDQ39	1.014	1.000-1.029	0.048

^a Significant results are highlighted in italic (). OR: odds ratio; CI: confidence interval; PDSS: the PD Sleep Scale; MOCA: Montreal Cognitive Assessment; HAMD: Hamilton Depression Rating Scale; RBDSQ: the REM Sleep Behavior Disorder Sleep Questionnaire; PDQ39: Parkinson’s Disease Questionnaire-39.